Bristol-Myers Squibb: Verification
 
Verification Statements

Bristol-Myers Squibb has obtained the following independent reviews:

  • Investor Carbon Disclosure Project - Accuracy of GHG Emissions & Water Withdrawal Assertions
  • Select Environmental Data – Independent Assurance Statement
  • GRI Application Level Check
  • EHS Evaluation Program Attestation
Investor Carbon Disclosure Project – Accuracy of GHG Emissions & Water Withdrawal Assertions

Bureau Veritas North America, Inc. (BVNA) was engaged to conduct an independent verification of the greenhouse gas (GHG) emissions and water withdrawal reported by Bristol Myers Squibb (BMS) for the period of January 1, 2012 to December 31, 2012. This Verification Statement applies to the related information included within the scope of work.

The determination of the GHG emissions and water withdrawal is the sole responsibility of BMS. BVNA’s sole responsibility was to provide independent verification on the accuracy of the GHG emissions and water withdrawal assertions, and on the underlying systems and processes used to collect, analyze and review the information.

A copy of the letter detailing the results of this assessment is available here. (PDF 79KB)

Select Environmental Data - Independent Assurance Statement

Bureau Veritas North America, Inc. (BVNA) was engaged by Bristol Myers Squibb (BMS) to conduct an independent assurance of select environmental data reported in its corporate social responsibility report (the Report). This Assurance Statement applies to the related information included within the scope of work which includes; Direct Greenhouse Gas (GHG) emissions (Scope 1) (excluding refrigerant emissions), Indirect GHG emissions (Scope 2), GHG emissions from business travel on commercial airlines (Scope 3), Energy Consumption and Water Withdrawal. The intended users of the assurance statement are the stakeholders of BMS. The overall aim of this process is to provide assurance to BMS’s stakeholders on the accuracy, reliability and objectivity of select information included in the Report.

The environmental data and its presentation in the Report are the sole responsibility of the management of BMS. BVNA was not involved in the collection of the information or the drafting of the Report.

A copy of the Independent Assurance Statement detailing the results of this assessment is available here. (PDF 35KB)

GRI Application Level Check

GRI hereby states that Bristol-Myers Squibb has presented its report “Sustainability Report” (2011) to GRI’s Report Services which have concluded that the report fulfills the requirement of Application Level B+.

GRI Application Levels communicate the extent to which the content of the G3 Guidelines has been used in the submitted sustainability reporting. The Check confirms that the required set and number of disclosures for that Application Level have been addressed in the reporting and that the GRI Content Index demonstrates a valid representation of the required disclosures, as described in the GRI G3 Guidelines. For methodology, see (www.globalreporting.org/SiteCollectionDocuments/ALC-Methodology.pdf 117KB)

A copy of the GRI Application Level Check B+ is available here. (PDF 325KB)

EHS Evaluation Program Attestation

“The Cadmus Group, Inc. (Cadmus) was requested by Bristol-Myers Squibb Company (BMS) to confirm that the Environment, Health and Safety (EHS) Evaluation Program is being implemented in accordance with the Corporate Environment, Health, Safety and Sustainability (CEHSS) Standard Operating Procedure (SOP) - ADM-007, Version 9.

In Cadmus’ opinion, the EHS Evaluation Program is designed and implemented in an effective and value-added manner, consistent with the provisions of ADM-007, the global audit standards issued by the Board of Environmental, Health, and Safety Certifications (BEAC), and Annex III under the Eco-Management and Audit Scheme Regulation. The program features several exemplary practices and provides an objective and thoughtful analysis of EHS performance across the organization. Our opinion is based on data gathered during September through November 2013…”

Several exemplary practices including the allocation of time and staff resources by evaluation teams, the leadership shown by Lead Evaluators, and the completion rates for corrective action resolution were noted in the EHS Evaluation Program Attestation, a full copy of which is available here. (PDF 60KB).

 
 
 
 


You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.
You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.